- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/0783 - T cellsNK cellsProgenitors of T or NK cells
Patent holdings for IPC class C12N 5/0783
Total number of patents in this class: 11800
10-year publication summary
|
315
|
474
|
639
|
846
|
927
|
1051
|
1210
|
1110
|
1211
|
1032
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1155 |
686 |
| Iovance Biotherapeutics, Inc. | 345 |
258 |
| The Regents of the University of California | 20195 |
236 |
| The Trustees of the University of Pennsylvania | 4374 |
211 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2892 |
150 |
| Board of Regents, The University of Texas System | 5906 |
149 |
| Cellectis | 402 |
130 |
| Memorial Sloan-Kettering Cancer Center | 1968 |
120 |
| Juno Therapeutics, Inc. | 446 |
116 |
| Baylor College of Medicine | 966 |
109 |
| The Board of Trustees of the Leland Stanford Junior University | 6507 |
102 |
| Novartis AG | 10685 |
99 |
| City of Hope | 1004 |
88 |
| Immunitybio, Inc. | 443 |
88 |
| Autolus Limited | 259 |
86 |
| Kite Pharma, Inc. | 409 |
82 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 975 |
79 |
| Regents of the University of Minnesota | 2722 |
75 |
| FATE Therapeutics, Inc. | 211 |
72 |
| Kyoto University | 2835 |
69 |
| Other owners | 8795 |